ReP USP - Resultado da busca

Artigo de periodico
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability (2025)
Pereira-Martins, Diego A.; Weinhauser, Isabel; Griessinger, Emmanuel; Coelho-Silva, Juan L.; Silveira, Douglas R.; Sternadt, Dominique; Erdem, Aysegul; Duarte, Bruno Kosa L.; Chatzikyriakou, Prodromos; Rego, Eduardo Magalhães
Source: Signal Transduction and Targeted Therapy. Unidade: FM
Subjects: LEUCEMIA MIELOIDE AGUDA, APOPTOSE, VULNERABILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA-MARTINS, Diego A. et al. High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability. Signal Transduction and Targeted Therapy, v. 10, n. 1, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/89112. Acesso em: 30 abr. 2026.
APA
Pereira-Martins, D. A., Weinhauser, I., Griessinger, E., Coelho-Silva, J. L., Silveira, D. R., Sternadt, D., et al. (2025). High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability. Signal Transduction and Targeted Therapy, 10( 1). doi:10.1038/s41392-025-02303-x
NLM
Pereira-Martins DA, Weinhauser I, Griessinger E, Coelho-Silva JL, Silveira DR, Sternadt D, Erdem A, Duarte BKL, Chatzikyriakou P, Rego EM. High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability [Internet]. Signal Transduction and Targeted Therapy. 2025 ; 10( 1):[citado 2026 abr. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/89112
Vancouver
Pereira-Martins DA, Weinhauser I, Griessinger E, Coelho-Silva JL, Silveira DR, Sternadt D, Erdem A, Duarte BKL, Chatzikyriakou P, Rego EM. High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability [Internet]. Signal Transduction and Targeted Therapy. 2025 ; 10( 1):[citado 2026 abr. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/89112
Artigo de periodico-carta/editorial
Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia. [Carta] (2024)
Salustiano-Bandeira, Maria L.; Moreira-Aguiar, Amanda; Martins, Diego Antonio Pereira; Coelho-Silva, Juan Luiz ; Weinhauser, Isabel; Franca-Neto, Pedro L.; Lima, Aleide S.; Yamada, Ana Silvia Gouvêa; Baccarin, Anemari R. D.; Silva, Fernanda B.; Melo, Manuela Albuquerque de ; Niemann, Fernanda Soares; Nardinelli, Luciana ; Rojas, César Alexander Ortiz ; Duarte, Bruno K.; Araújo, Aderson S.; Azevedo, Elisa A.; Morais, Clarice N.; Figueiredo-Pontes, Lorena Lobo ; Schuringa, Jan Jacob; Huls, Gerwin A.; Bendit, Israel ; Rego, Eduardo Magalhães ; Saad, Sara Teresinha Olalla; Traina, Fabiola ; Bezerra, Marcos A.; Lucena-Araújo, Antonio Roberto
Source: Blood Cancer Journal. Unidades: FMRP, FM
Subjects: REGULAÇÃO GÊNICA, LEUCEMIA MIELOIDE AGUDA, PROTEÍNAS NUCLEARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALUSTIANO-BANDEIRA, Maria L. et al. Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia. [Carta]. Blood Cancer Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41408-024-01086-8. Acesso em: 30 abr. 2026. , 2024
APA
Salustiano-Bandeira, M. L., Moreira-Aguiar, A., Martins, D. A. P., Coelho-Silva, J. L., Weinhauser, I., Franca-Neto, P. L., et al. (2024). Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia. [Carta]. Blood Cancer Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1038/s41408-024-01086-8
NLM
Salustiano-Bandeira ML, Moreira-Aguiar A, Martins DAP, Coelho-Silva JL, Weinhauser I, Franca-Neto PL, Lima AS, Yamada ASG, Baccarin ARD, Silva FB, Melo MA de, Niemann FS, Nardinelli L, Rojas CAO, Duarte BK, Araújo AS, Azevedo EA, Morais CN, Figueiredo-Pontes LL, Schuringa JJ, Huls GA, Bendit I, Rego EM, Saad STO, Traina F, Bezerra MA, Lucena-Araújo AR. Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia. [Carta] [Internet]. Blood Cancer Journal. 2024 ; 14( 1): 1-3.[citado 2026 abr. 30 ] Available from: https://doi.org/10.1038/s41408-024-01086-8
Vancouver
Salustiano-Bandeira ML, Moreira-Aguiar A, Martins DAP, Coelho-Silva JL, Weinhauser I, Franca-Neto PL, Lima AS, Yamada ASG, Baccarin ARD, Silva FB, Melo MA de, Niemann FS, Nardinelli L, Rojas CAO, Duarte BK, Araújo AS, Azevedo EA, Morais CN, Figueiredo-Pontes LL, Schuringa JJ, Huls GA, Bendit I, Rego EM, Saad STO, Traina F, Bezerra MA, Lucena-Araújo AR. Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia. [Carta] [Internet]. Blood Cancer Journal. 2024 ; 14( 1): 1-3.[citado 2026 abr. 30 ] Available from: https://doi.org/10.1038/s41408-024-01086-8
Artigo de periodico
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia (2023)
Pereira-Martins, Diego A; Coelho-Silva, Juan L; Weinhauser, Isabel; Franca-Neto, Pedro L; Silveira, Douglas R; Ortiz, Cesar; Moreira-Aguiar, Amanda; Lima, Marinus M; Koury, Luisa C; Rego, Eduardo Magalhães ; Traina, Fabiola ; Pontes, Lorena Lobo de Figueiredo
Source: British journal of haematology. Unidades: FM, FMRP
Subjects: RECIDIVA, LEUCEMIA MIELOIDE, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA-MARTINS, Diego A et al. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia. British journal of haematology, v. 200, n. 2, p. 170-174, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/51415. Acesso em: 30 abr. 2026.
APA
Pereira-Martins, D. A., Coelho-Silva, J. L., Weinhauser, I., Franca-Neto, P. L., Silveira, D. R., Ortiz, C., et al. (2023). Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia. British journal of haematology, 200( 2), 170-174. doi:10.1111/bjh.18510
NLM
Pereira-Martins DA, Coelho-Silva JL, Weinhauser I, Franca-Neto PL, Silveira DR, Ortiz C, Moreira-Aguiar A, Lima MM, Koury LC, Rego EM, Traina F, Pontes LL de F. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia [Internet]. British journal of haematology. 2023 ; 200( 2): 170-174.[citado 2026 abr. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/51415
Vancouver
Pereira-Martins DA, Coelho-Silva JL, Weinhauser I, Franca-Neto PL, Silveira DR, Ortiz C, Moreira-Aguiar A, Lima MM, Koury LC, Rego EM, Traina F, Pontes LL de F. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia [Internet]. British journal of haematology. 2023 ; 200( 2): 170-174.[citado 2026 abr. 30 ] Available from: https://observatorio.fm.usp.br/handle/OPI/51415
Trabalho de evento-resumo periodico
Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines (2017)
Pereira-Martins, Diego A.; Weinhauser, Isabel; Almeida, Luciana Yamamoto de; Scheucher, Priscila Santos; Wagatsuma, Virgínia Mara de Deus; Lucena-Araújo, Antonio Roberto; Rego, Eduardo Magalhães
Source: Revista Brasileira de Hematologia e Hemoterapia. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO 2017). Unidade: FMRP
Subjects: LEUCEMIA, PROTEÍNAS, HEMATOPOESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA-MARTINS, Diego A. et al. Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf. Acesso em: 30 abr. 2026. , 2017
APA
Pereira-Martins, D. A., Weinhauser, I., Almeida, L. Y. de, Scheucher, P. S., Wagatsuma, V. M. de D., Lucena-Araújo, A. R., & Rego, E. M. (2017). Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf
NLM
Pereira-Martins DA, Weinhauser I, Almeida LY de, Scheucher PS, Wagatsuma VM de D, Lucena-Araújo AR, Rego EM. Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39[citado 2026 abr. 30 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf
Vancouver
Pereira-Martins DA, Weinhauser I, Almeida LY de, Scheucher PS, Wagatsuma VM de D, Lucena-Araújo AR, Rego EM. Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39[citado 2026 abr. 30 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Non normalized affiliation